Late Breaking Abstract - Airway morphogenesis in wild type and heterozygous F508del mouse embryonic lungs treated by Elexacaftor/Tezacaftor/Ivacaftor

A. Hadchouel-Duvergé (Paris, France), M. Lhuillier (Québec, Canada), L. Aoust (Paris, France), E. Dreano (Paris, France), K. Landry Truchon (Québec, Canada), C. Delacourt (Paris, France), L. Jeanotte (Québec, Canada), I. Sermet Gaudelus (Paris, France)

Source: International Congress 2022 – Identifying therapeutic targets and novel drug strategies in pulmonary diseases

Session: Identifying therapeutic targets and novel drug strategies in pulmonary diseases
Session type: Thematic Poster
Number: 2844

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Hadchouel-Duvergé (Paris, France), M. Lhuillier (Québec, Canada), L. Aoust (Paris, France), E. Dreano (Paris, France), K. Landry Truchon (Québec, Canada), C. Delacourt (Paris, France), L. Jeanotte (Québec, Canada), I. Sermet Gaudelus (Paris, France). Late Breaking Abstract - Airway morphogenesis in wild type and heterozygous F508del mouse embryonic lungs treated by Elexacaftor/Tezacaftor/Ivacaftor. 2844

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.